tiprankstipranks
Immunic (IMUX)
NASDAQ:IMUX
Holding IMUX?
Track your performance easily

Immunic (IMUX) Financial Statements

1,253 Followers

Immunic Financial Overview

Immunic's market cap is currently ―. The company's EPS TTM is $-1.239; its P/E ratio is -0.86; Immunic is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -24.37M$ -21.38M$ -24.79M$ -23.38M$ -23.57M
EBITDA$ -24.33M$ -21.35M$ -24.76M$ -23.36M$ -23.54M
Net Income Common Stockholders$ -24.37M$ -21.38M$ -29.58M$ -21.57M$ -22.77M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 59.07M$ 79.70M$ 97.31M$ 46.67M$ 59.70M
Total Assets$ 64.76M$ 86.49M$ 104.16M$ 54.30M$ 66.98M
Total Debt$ 186.00K$ 241.00K$ 433.00K$ 639.00K$ 789.00K
Net Debt$ -58.88M$ -79.46M$ -96.88M$ -46.03M$ -58.91M
Total Liabilities$ 23.54M$ 22.92M$ 20.58M$ 25.37M$ 18.57M
Stockholders Equity$ 41.22M$ 63.53M$ 83.58M$ 28.93M$ 48.41M
Cash Flow-
Free Cash Flow$ -20.85M$ -17.21M$ -24.00M$ -14.19M$ -17.36M
Operating Cash Flow$ -20.80M$ -17.03M$ -23.97M$ -14.03M$ -17.31M
Investing Cash Flow$ -50.00K$ -180.00K$ -31.00K$ -165.00K$ -44.00K
Financing Cash Flow--$ 74.46M$ 604.00K$ 282.00K
Currency in USD

Immunic Earnings and Revenue History

Immunic Debt to Assets

Immunic Cash Flow

Immunic Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis